All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - aspirin
Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation: Results From the PTRG-DES Consortium
Read more...
Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using aspirin and prasugrel
Read more...
High On-Treatment Platelet Reactivity as Predictor of Long-term Clinical Outcomes in Stroke Patients with Antiplatelet Agents
Read more...
Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
Read more...
Management of antiplatelet therapy in patients undergoing neuroendovascular procedures
Read more...
Variability of Platelet Reactivity on Antiplatelet Therapy in Neurointervention Procedure
Read more...
Antiplatelet Therapy in Flow Diversion
Read more...
Treatment of Bilateral Giant Fusiform Petrocavernous Aneurysms
Read more...
Initial experience with the novel p64MW HPC flow diverter from a cohort study in unruptured anterior circulation aneurysms under dual antiplatelet medication
Read more...
Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
Read more...
High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial
Read more...
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Read more...
Posttreatment platelet reactivity on clopidogrel is associated with the risk of adverse events after off-pump coronary artery bypass
Read more...
Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery
Read more...
Reduced Effect of Aspirin and Clopidogrel Following Hybrid Coronary Revascularization
Read more...
Utility of VerifyNow for Point-of-Care Identification of an Aspirin Effect Prior to Emergency Cardiac Surgery
Read more...
Platelet Reactivity Unit in Predicting Risk of Bleeding in Patients Undergoing Coronary Artery Bypass Graft Surgery
Read more...
Assessment of Bleeding and Thrombosis Based on Aspirin Responsiveness after Continuous-Flow Left Ventricular Assist Device Placement
Read more...
The absorption of aspirin is reduced after coronary artery bypass grafting
Read more...
Weight as an assay-independent predictor of poor response to enteric aspirin in cardiovascular patients
Read more...
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Read more...
Platelet Activity Measured by VerifyNow® Aspirin Sensitivity Test Identifies Coronary Artery Bypass Surgery Patients at Increased Risk for Postoperative Bleeding and Transfusion
Read more...
Assessment of platelet function after discontinuation of ticagrelor
Read more...
Increased platelet inhibition after switching from prasugrel to low-dose ticagrelor in Japanese patients with prior myocardial infarction
Read more...
Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy
Read more...
Evening aspirin intake results in higher levels of platelet inhibition and a reduction in reticulated platelets - a window of opportunity for patients with cardiovascular disease?
Read more...
Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial
Read more...
The Effect of Low-Dose Ticagrelor on Platelet Function Profiles in Patients With Stable Coronary Artery Disease in Trinidad: The TWIST Pilot Study
Read more...
Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes
Read more...
Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity
Read more...
Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study
Read more...
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the Euro
Read more...
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y 12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Read more...
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection